Lcnb Corp Eli Lilly & CO Transaction History

Lcnb Corp

$267 Million
Q2 2024

A detailed history of Lcnb Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Lcnb Corp holds 2,051 shares of LLY stock, worth $1.7 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

2,051

Previous 2,285 10.24%

Holding current value

$1.7 Million

Previous $1.78 Million 4.45%

% of portfolio

0.7%

Previous 0.65%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $169,619 - $212,715	-234 Reduced 10.24%	2,051 $1.86 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $24,158 - $28,479	-46 Reduced 1.97%	2,285 $1.33 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $19,561 - $26,968	-45 Reduced 1.89%	2,331 $1.25 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $192,907 - $257,939	-550 Reduced 18.8%	2,376 $1.11 Million
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $72,687 - $85,367	-234 Reduced 7.41%	2,926 $1 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $6,431 - $7,493	20 Added 0.64%	3,160 $1.16 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $185,355 - $217,634	665 Added 26.87%	3,140 $1.02 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $44,320 - $54,541	-200 Reduced 7.48%	2,475 $572,000
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $13,541 - $17,515	75 Added 2.88%	2,675 $614,000
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $131,456 - $170,176	-800 Reduced 23.53%	2,600 $486,000
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $2,217 - $2,934	17 Added 0.5%	3,400 $574,000
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $29,244 - $33,826	-200 Reduced 5.58%	3,383 $501,000
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $10,231 - $12,313	-75 Reduced 2.05%	3,583 $588,000
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $54,643 - $67,633	459 Added 14.35%	3,658 $507,000
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $342,037 - $423,643	3,199 New	3,199 $420,000

Others Institutions Holding LLY

# of Institutions

3,912

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.95M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $788B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.

Account